PR Newswire: news distribution, targeting and monitoring
2014

Mike Withrow, Abattis Bioceuticals Corp. CEO, is Interviewed on CEONews.Tv

Company Combines Management Expertise and Changes in Law to Position For Growth

Share with Twitter Share with LinkedIn

VANCOUVER, British Columbia, Jan. 24, 2013 /PRNewswire/ -- CEO Mike Withrow of Abattis Bioceuticals Corp.  www.abattis.com (OTCPINK: ATTBF) (CNSX: FLU), a specialty biotechnology company engaged in the licensing, marketing and formulation of unique and proprietary botanical, vitamin, and mineral products in several high growth natural health categories, has been interviewed on CEONews.Tv, a financial news network. The interview is available at: http://www.ceonews.tv/attbf/

In the interview Withrow said, "We are currently examining various botanical plants... for compounds and ingredients to go into our natural health products, that are proprietary to our company, to give us that competitive edge in the market."

He also pointed out that recent changes in the laws of the states of Washington and Colorado, concerning the decriminalization and legalization of marijuana, have presented new opportunities for Abattis. He said that "we see that as quite a large opportunity to get into a fragmented business." He went on to state that "we have the ability to be a pharmaceutical grade production facility with the equipment we have and the way that it is designed."

In conclusion, Mr. Withrow shared his confidence in and his vision for the future of Abattis Bioceuticals - "We have intellectual property. We have a great pipeline of products. We have great people that have proven themselves in Fortune 100 companies... and we think that there's great value."

About Abattis Bioceuticals Corp.:
Abattis Bioceuticals Corp. is a specialty biotechnology company with capabilities, through its wholly owned subsidiaries, of producing, licensing and marketing proprietary ingredients and bio-similar compounds for use in Pharmaceuticals, Nutraceutical, Cosmetic and Animal Nutrition markets. The company also has a deep pipeline of proprietary products ready for sale in the high growth sectors of the Functional Foods and Supplements business. For more information, visit the Company's website at www.abattis.com.

About CEONews:
CEONews.Tv (a division of West-Main Communications, LLC) is an online, market news provider that brings investors – "Big News For The SmallCap Market!"TM. CEONews.Tv offers a number of innovative platforms that allow CEOs, CFOs, COOs, Presidents and Directors of companies to deliver answers to the questions that investors would like asked. Through these mediums Executives share their insights, accomplishments, current projects, daily challenges they face and future goals and aspirations they have for the companies that they lead. For further information please visit http://www.ceonews.tv, send an email to: interviews@ceonews.tv or call 765-CEONEWS (236-6397).

Contacts:
Abattis Bioceuticals Corp.
Mike Withrow President & CEO
778.908.6650
www.abattis.com

CEONews.Tv
Charles Sample II
765-CEO-NEWS (236-6397)
charles@ceonews.tv
interviews@ceonews.tv
www.ceonews.tv

SOURCE CEONews.Tv



RELATED LINKS
http://www.ceonews.tv

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn
 

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

 
 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

 
 

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

 

Online Member Center

Not a Member?
Click Here to Join
Login
Search News Releases
Advanced Search
Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release